↓ Skip to main content

mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients

Overview of attention for article published in Frontiers in oncology, March 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
11 news outlets
blogs
2 blogs
twitter
34 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
mRNA-COVID19 Vaccination Can Be Considered Safe and Tolerable for Frail Patients
Published in
Frontiers in oncology, March 2022
DOI 10.3389/fonc.2022.855723
Pubmed ID
Authors

Maria Teresa Lupo-Stanghellini, Serena Di Cosimo, Massimo Costantini, Sara Monti, Renato Mantegazza, Alberto Mantovani, Carlo Salvarani, Pier Luigi Zinzani, Matilde Inglese, Fabio Ciceri, Giovanni Apolone, Gennaro Ciliberto, Fausto Baldanti, Aldo Morrone, Valentina Sinno, Franco Locatelli, Stefania Notari, Elena Turola, Diana Giannarelli, Nicola Silvestris

X Demographics

X Demographics

The data shown below were collected from the profiles of 34 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 59 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 10%
Student > Master 5 8%
Professor 3 5%
Student > Doctoral Student 3 5%
Student > Postgraduate 3 5%
Other 8 14%
Unknown 31 53%
Readers by discipline Count As %
Medicine and Dentistry 12 20%
Nursing and Health Professions 5 8%
Neuroscience 3 5%
Business, Management and Accounting 2 3%
Agricultural and Biological Sciences 1 2%
Other 4 7%
Unknown 32 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 112. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 December 2022.
All research outputs
#402,010
of 26,538,769 outputs
Outputs from Frontiers in oncology
#62
of 23,241 outputs
Outputs of similar age
#11,154
of 470,626 outputs
Outputs of similar age from Frontiers in oncology
#3
of 1,539 outputs
Altmetric has tracked 26,538,769 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 23,241 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 470,626 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 1,539 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.